Related Experiment Video
Updated: Oct 27, 2025

Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs
Published on: August 8, 2022
Advances in 3D-Printed Surface-Modified Ca-Si Bioceramic Structures and Their Potential for Bone Tumor Therapy.
Linh B Truong1, David Medina Cruz1, Ebrahim Mostafavi1,2,3
1Department of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.
This review explores the use of 3D-printed calcium silicate (Ca-Si) bioceramic scaffolds for bone tumor therapy. Traditional methods of making these scaffolds have limitations in achieving the structural complexity needed for effective treatment. 3D printing allows for precise control over the scaffold's architecture, enabling the integration of photothermal materials. These materials help in killing cancerous cells while promoting healthy bone tissue regeneration. The study also examines how surface and internal modifications of the scaffolds enhance their therapeutic potential. The findings suggest that 3D-printed Ca-Si scaffolds offer a promising dual-function platform for cancer treatment and tissue regeneration. The review highlights the advantages of 3D printing in creating reproducible and scalable bioceramic structures for biomedical applications.
Area of Science:
- 3D printing in biomedical materials
- Cancer therapy using bioceramics
Background:
Traditional bioceramic scaffolds face limitations in achieving optimal structural complexity for photothermal therapy and drug delivery. These scaffolds are known for their mechanical stability and biocompatibility, making them suitable for bone regeneration and cancer treatment. However, conventional fabrication methods hinder the development of macro-, micro-, and nanostructures necessary for enhanced therapeutic outcomes. Researchers have explored alternative fabrication techniques to overcome these constraints. 3D printing has emerged as a promising solution, enabling precise control over scaffold architecture. This method supports the creation of complex geometries and reproducible structures. Surface modification of bioceramics remains a key challenge in maximizing their therapeutic potential. The need for scalable and sustainable fabrication methods has driven recent innovations in the field. This gap motivated the exploration of 3D printing as a novel approach for bioceramic scaffold development.
Purpose Of The Study:
This review aims to evaluate the use of 3D printing for fabricating surface-modified calcium silicate (Ca-Si) bioceramic scaffolds. The goal is to assess how these scaffolds can be optimized for photothermal therapy and drug delivery in bone tumor treatment. The study focuses on the functionalization of both external and internal scaffold surfaces. Researchers sought to identify the most effective photothermal materials for integration into Ca-Si scaffolds. The review also examines how 3D printing enables precise control over scaffold architecture. The motivation stems from the limitations of traditional synthesis methods in achieving structural complexity. The study highlights the potential of 3D-printed Ca-Si as a dual-function platform for cancer treatment and tissue regeneration. This approach addresses the need for scalable and reproducible fabrication techniques in biomedical applications.
Main Methods:
The researchers conducted a comprehensive literature review on 3D-printed Ca-Si bioceramic scaffolds. They analyzed studies that describe the integration of photothermal materials into these scaffolds. The review focused on surface modification techniques and internal dispersion strategies. The authors evaluated the structural and functional properties of 3D-printed Ca-Si scaffolds. They compared traditional synthesis methods with 3D printing in terms of structural control. The study examined how scaffold architecture influences photothermal and drug delivery performance. Researchers assessed the reproducibility and scalability of 3D printing for bioceramic fabrication. The review also considered the mechanical stability and biocompatibility of the resulting scaffolds.
Main Results:
3D-printed Ca-Si scaffolds demonstrated enhanced structural control at macro, micro, and nano levels. The integration of photothermal materials improved the scaffolds' ability to kill cancerous cells. Surface modification significantly increased the scaffolds' photothermal efficiency. Internal dispersion of functional materials enhanced drug delivery capabilities. The scaffolds showed high mechanical stability and biocompatibility in preclinical models. 3D printing allowed for the fabrication of complex geometries not achievable with traditional methods. The study reported reproducible results across multiple scaffold designs. The findings suggest that 3D printing offers a scalable and sustainable method for bioceramic scaffold production.
Conclusions:
The authors propose that 3D printing is a viable method for fabricating Ca-Si bioceramic scaffolds. Surface and internal functionalization of these scaffolds enhances their therapeutic potential. The study suggests that 3D-printed Ca-Si scaffolds can serve as dual-function platforms for cancer treatment and tissue regeneration. The integration of photothermal materials supports targeted cancer cell destruction. The scaffolds' structural complexity improves drug delivery efficiency. The authors suggest that 3D printing enables reproducible and scalable scaffold fabrication. The findings indicate that 3D-printed Ca-Si scaffolds outperform traditional bioceramics in structural and functional properties. The review highlights the potential of these scaffolds for future clinical applications.
Frequently Asked Questions
The scaffolds combine photothermal effects with drug delivery to target cancerous cells while promoting tissue regeneration.
Photothermal materials are integrated into the scaffolds to enhance their therapeutic capabilities.
Surface modification increases the scaffolds' photothermal efficiency and drug delivery performance.
Internal dispersion of functional materials improves the scaffolds' ability to deliver anticancer drugs.
3D printing enables precise control over macro, micro, and nanostructures, which enhances therapeutic outcomes.
The authors propose that 3D-printed Ca-Si scaffolds may offer a scalable and sustainable approach for bone tumor therapy.

